` EPN (Epsilon Healthcare Ltd) vs S&P/ASX 300 Comparison - Alpha Spread

E
EPN
vs
S
S&P/ASX 300

Over the past 12 months, EPN has significantly outperformed S&P/ASX 300, delivering a return of +54% compared to the S&P/ASX 300's +5% growth.

Stocks Performance
EPN vs S&P/ASX 300

Loading
EPN
S&P/ASX 300
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
EPN vs S&P/ASX 300

Performance Gap Between EPN and AXKO
HIDDEN
Show

Performance By Year
EPN vs S&P/ASX 300

Loading
EPN
S&P/ASX 300
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Epsilon Healthcare Ltd vs Peers

S&P/ASX 300
EPN
LLY
JNJ
ROG
AZN
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Epsilon Healthcare Ltd
Glance View

Market Cap
13.7m AUD
Industry
Pharmaceuticals

Epsilon Healthcare Ltd. manufactures and distributes hydroponics equipment, materials, and nutrients; and develops and delivers medical cannabis. The company is headquartered in Sydney, New South Wales. The company went IPO on 2017-05-04. The firm owns and operates end to end commercial medicinal cannabis production facilities. The firm operates through two segments: Manufacture and distribution of hydroponics equipment, materials and nutrients and development and delivery of medicinal cannabis. The firm also owns and operates turnkey cultivation solutions provider, including a hydroponics equipment and supplies wholesaler and retailer servicing the rapidly expanding cannabis sectors in North America and Europe.

EPN Intrinsic Value
HIDDEN
Show
Back to Top